Conduet Royalty Holdings

Conduet is a specialized healthcare investment firm focused on the acquisition and management of royalty interests in pharmaceutical and biotechnology products. The company provides non-dilutive capital to academic institutions, research hospitals, and biotechnology companies by purchasing future royalty streams from approved or late-stage clinical assets. Led by a team of experienced professionals from the royalty finance and investment industries, Conduet employs a rigorous analytical approach to evaluate therapeutic assets across a wide range of medical fields. By focusing on high-value, durable products, the firm aims to build a diversified portfolio of royalties that generate consistent returns. Conduet's model allows originators to monetize their intellectual property while providing the firm with exposure to the commercial success of innovative therapies.